Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Preferred Equity

Rigel Pharmaceuticals Preferred Equity Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Preferred Equity from 2020 to 2020.
Other Balance Sheet Metrics:
  • Rigel Pharmaceuticals Total Assets for the quarter ending September 09, 2018 was $123m a 3.29% increase of 4m year over year
  • Rigel Pharmaceuticals Other Liabilities for the quarter ending December 12, 2018 was $1m a 91.46% increase of 1m year over year
  • Rigel Pharmaceuticals Total Equity for the quarter ending September 09, 2018 was $103m a 2.73% increase of 3m year over year
View Chart On Koyfin